BIOMAT Database Logo BIOMAT Database Logo

Serum thyroglobulin concentration in nontoxic goiter and response to surgery with special reference to risk of goiter relapse. 1986

U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas

UI MeSH Term Description Entries
D008297 Male Males
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006042 Goiter Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC). Goiters
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Increased serum thyroglobulin levels in patients with nontoxic goiter.
April 1978, The Journal of clinical endocrinology and metabolism,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Thyroglobulin and calcitonin in patients with nontoxic goiter.
November 1978, JAMA,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Serum thyroglobulin in patients undergoing subtotal thyroidectomy for toxic and nontoxic goiter.
January 1982, Journal of endocrinological investigation,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Morphometric investigation of the human thyroid gland. With special reference to the methods and to nontoxic goiter.
December 1986, Analytical and quantitative cytology and histology,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine following partial thyroidectomy for nontoxic nodular goiter.
July 1988, Metabolism: clinical and experimental,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Defective intrathyroidal iodine metabolism in nontoxic goiter: inadequate iodination of thyroglobulin.
September 1968, The Journal of clinical endocrinology and metabolism,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Intussusception, with Special Reference to Relapse.
October 1903, Glasgow medical journal,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
[Goiter and cancer, with special reference to prevention].
January 1956, Strahlentherapie,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
[After care of differentiated thyroid gland carcinoma with special reference to serum thyroglobulin level].
September 1987, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
U Feldt-Rasmussen, and M Blichert-Toft, and J Date, and V Haas
Effect of therapy on the serum thyroglobulin concentration in patients with toxic diffuse goiter, toxic nodular goiter and toxic adenoma.
August 1987, Journal of endocrinological investigation,
Copied contents to your clipboard!